Leede Jones Gable Expands Capital Markets Team

(TheNewswire)

CALGARY – TheNewswire - October 13, 2020 – Leede Jones Gable continues to grow its capital markets team, adding strength in healthcare and biotechnology and building on recent additions in sales and trading.

Joining the firm are Michael Lorimer and Doug Loe, who bring more than two decades of senior capital markets experience in healthcare investment banking and research at Canadian investment houses.

Michael Lorimer has raised billions of dollars in growth capital for promising companies and advised on numerous M&A mandates. Doug Loe is one of Canada’s pre-eminent healthcare and biotechnology analysts, recognized by both Starmine and Brendan Wood International.

These new hires follow the recent arrival of Pat McCarthy, Sean Riley, Asha Khosla and Matt Green, who have all joined Leede Jones Gable Capital Markets this year.

“We are thrilled to have Michael and Doug join the firm. We now have the critical mass we need to service our corporate clients. With the new reality of life with Covid-19, we are all more focused on health and wellness,” said Jim Dale, CEO of Leede Jones Gable. “This top-ranked healthcare team is known for finding great investment ideas in healthcare IT, biotechnology, specialty pharma, and med-tech. It is a theme that is very timely and appealing to our retail and institutional clients.”

About Leede Jones Gable
Leede Jones Gable is a mid-size investment firm with offices across Canada and over 150 investment advisors and portfolio managers. We are one of the few full-service dealers not owned by a bank or life insurance company. We are owned by our employees, and that sets the stage for our firm’s ambition and culture. In its 2019 Brokerage Report Card, Investment Executive ranked us the top investment firm in Canada.

FOR MORE INFORMATION CONTACT

Jim Dale, CEO
Leede Jones Gable Inc.
(403) 531-6852
[email protected]

***

Copyright (c) 2020 TheNewswire - All rights reserved.

Disclaimer :: Use of this site is subject to, and your continued use constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information. INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion; however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment. Users should always consult with and obtain advice from their professional licensed financial advisor, including their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment or trading securities do so with caution. Users should perform full due diligence and investigate any security fully before making an investment or before the execution of a security trade based upon information learned through INK. Investors should obtain annual reports and other company information to complete their own due diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this website. On this site, there may be third party content, content from authors or links to third-party sites or pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI® is a registered trade-mark owned by the Alberta Securities Commission.Read less

Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.

Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.